Phase Two - Better Than the Phase Too Well?

In phase two, awhat we are doing is refining our method figuring out if we could do a double blind study. The challenge would be to find the dose of mdma that was high enough to cause some confusion, but not so high that you could never tell a difference between the two groups. And at the one year follow up, what we showed is that two thirds no longer had petieste. So what that is phenomenal, because what it showed is that people still keep getting better on their own afterwards. That gives us hope that this will be both introduced and adopted, and we can really scale it.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.